Table 3.
Compound | [M + Na]+ m/z | MS/MS (%) |
---|---|---|
3-Hydroxypropyl-GLS | 320 | 219 (2) [(M + Na)-RCNOH]+; 100 (100) [CH2CHCH2NCS + H]+; 72 (10) [CH2NCS]+ |
3-Hydroxybutyl-GLS | 334 | 219 (35) [(M + Na)-RCNOH]+; 100 (100) [CH2CHCH2NCS + H]+ |
Gluconapin (3-Butenyl-GLS) |
316 | 185 (3) [(M + Na)-RCNOH-H2S]+; 154 (2) [(M + Na)-Glu]+; 72 (10) [CH2NCS]+; 58 (19) [NCS]+ |
Isobutyl-GLS | 318 | 186 (2) [(M + Na)-RCNOH-H2S]+; 100 (100) [CH2CHCH2NCS + H]+; 72 (10) [CH2NCS]+ |
Glucoviorylin (2-(Methylthio)-ethyl-GLS) |
336 | 220 (38) [(M + Na)-RCNOH]+; 174 (2) [(M + Na)-Glu]+; 100 (100) [CH2CHCH2NCS + H]+; 72 (10) [CH2NCS]+ |
Glucoiberverin (3-(Methylthio)-propyl-GLS) |
350 | 219 (15) [(M + Na)-RCNOH]+; 100 (100) [CH2CHCH2NCS + H]+; 58 (13) [NCS]+ |
Glucotropaeolin (Benzyl-GLS) |
352 | 220 (2) [(M + Na)-RCNOH]+; 100 (100) [CH2CHCH2NCS + H]+; 72 (10) [CH2NCS]+ |
* Glucosinolates have been analyzed as desulphoglucosinolates.